Fund Holdings — Opaleye Management Inc.

Total Portfolio Value:
$376.07M
Total Bought:
$98.96M
Total Sold:
$60.05M
Net Transaction:
+$38.92M
Notable People:
James Aaron Silverman
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Harrow, Inc.(HROW)3,795,0003,820,000+25,000$54.53M$42.78M11.38%-$11.75M
TG Therapeutics, Inc.(TGTX)1,890,0002,215,000+325,000$15.80M$37.83M10.06%+$22.03M
Acelyrin Inc4,146,1384,146,1380$42.17M$30.93M8.22%-$11.24M
Rhythm Pharmaceuticals, Inc.(RYTM)653,000610,000-43,000$14.97M$28.04M7.46%+$13.07M
Ocular Therapeutix, Inc.(OCUL)6,468,0006,070,000-398,000$20.31M$27.07M7.20%+$6.76M
Catalyst Pharmaceuticals Inc1,205,0001,257,200+52,200$14.09M$21.44M5.70%+$7.35M
Keros Therapeutics, Inc.(KROS)360,400357,500-2,900$11.49M$14.21M3.78%+$2.72M
IDEAYA Biosciences, Inc.(IDYA)311,500311,5000$8.40M$11.08M2.95%+$2.68M
Eton Pharmaceuticals, Inc.(ETON)2,430,2702,529,887+99,617$10.13M$11.08M2.95%+$946.7K
Crinetics Pharmaceuticals Inc370,000307,500-62,500$11.00M$10.94M2.91%-$63.0K
Arvinas, Inc.(ARVN)0263,700+263,700$0$10.85M2.89%+$10.85M
Codexis, Inc.(CDXS)1,118,9003,045,525+1,926,625$2.11M$9.29M2.47%+$7.17M
Biohaven Ltd.(BHVN)439,000200,000-239,000$11.42M$8.56M2.28%-$2.86M
Edgewise Therapeutics, Inc.(EWTX)875,405699,000-176,405$5.02M$7.65M2.03%+$2.63M
Iovance Biotherapeutics, Inc.(IOVA)610,000897,000+287,000$2.78M$7.29M1.94%+$4.52M
Arcutis Biotherapeutics, Inc.(ARQT)01,960,000+1,960,000$0$6.33M1.68%+$6.33M
4d Molecular Therapeutics Inc308,500308,5000$3.93M$6.25M1.66%+$2.32M
Marinus Pharmaceuticals Inc584,000563,500-20,500$4.70M$6.13M1.63%+$1.42M
Vaxcyte, Inc.(PCVX)90,00090,0000$4.59M$5.65M1.50%+$1.06M
Liquidia Corporation(LQDA)570,700445,000-125,700$3.62M$5.35M1.42%+$1.74M
Protara Therapeutics, Inc.(TARA)2,692,5942,692,5940$4.50M$5.05M1.34%+$552.3K
UroGen Pharma Ltd.(URGN)320,000320,0000$4.48M$4.80M1.28%+$316.8K
Xoma Corp Del274,500250,000-24,500$3.87M$4.63M1.23%+$757.3K
Applied Therapeutics893,0001,092,500+199,500$2.22M$3.66M0.97%+$1.44M
Relmada Therapeutics, Inc.(RLMD)30,000877,000+847,000$90.0K$3.63M0.97%+$3.54M
Biodesix, Inc.(BDSX)455,573496,500+40,927$3.04M$3.61M0.96%+$572.4K
Trevi Therapeutics, Inc.(TRVI)1,705,9002,535,000+829,100$3.72M$3.40M0.90%-$322.0K
Jasper Therapeutics, Inc.(JSPR)03,985,340+3,985,340$0$3.14M0.84%+$3.14M
Intellia Therapeutics, Inc.(NTLA)099,000+99,000$0$3.02M0.80%+$3.02M
Newamsterdam Pharma Company
ORDINARY SHARES
0265,388+265,388$0$2.96M0.79%+$2.96M
Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS)8,000,0000-8,000,000$3.10M$2.92M0.78%-$183.6K
Larimar Therapeutics, Inc.(LRMR)848,500623,500-225,000$3.35M$2.84M0.75%-$514.6K
Ventyx Biosciences Inc01,140,000+1,140,000$0$2.82M0.75%+$2.82M
Syros Pharmaceuticals Inc0359,370+359,370$0$2.80M0.74%+$2.80M
Gossamer Bio, Inc.(GOSS)4,754,2002,982,200-1,772,000$3.96M$2.72M0.72%-$1.24M
Protagonist Therapeutics Inc0112,700+112,700$0$2.58M0.69%+$2.58M
Kalvista Pharmaceuticals Inc500,000150,000-350,000$4.82M$1.84M0.49%-$2.98M
Verastem, Inc.(VSTM)211,400211,4000$1.72M$1.72M0.46%+$2.1K
Nyxoah S ASHS
SHS
441,896344,800-97,096$3.12M$1.60M0.43%-$1.52M
Morphosys AgADS1,209,380145,000-1,064,380$8.13M$1.44M0.38%-$6.69M
Precigen, Inc.(PGEN)928,5001,012,500+84,000$1.32M$1.36M0.36%+$38.3K
Sutro Biopharma, Inc.(STRO)0301,491+301,491$0$1.29M0.34%+$1.29M
Context Therapeutics Inc.(CNTX)0975,000+975,000$0$1.10M0.29%+$1.10M
Fulcrum Therapeutics, Inc.(FULC)0130,000+130,000$0$877.5K0.23%+$877.5K
Aligos Therapeutics Inc01,297,000+1,297,000$0$861.2K0.23%+$861.2K
Kiniksa Pharmaceuticals LtdCL A037,500+37,500$0$640.2K0.17%+$640.2K
FORTRESS BIOTECH INCCOM(FBIO)2,000,0000-2,000,000$580.6K$0—-$580.6K
GERON CORPCOM(GERN)1,915,0000-1,915,000$4.06M$0—-$4.06M
IGM BIOSCIIENCES INCCOM261,0000-261,000$2.18M$0—-$2.18M
KEZAR LIFE SCIENCES INCCOM425,0000-425,000$505.8K$0—-$505.8K
TELA BIO INCCOM(TELA)750,0000-750,000$6.00M$0—-$6.00M
TRACON PHARMACEUTICALS INCCOM NEW4,764,5080-4,764,508$848.1K$0—-$848.1K
XERIS BIOPHARMA HOLDINGS INCCOM390,0000-390,000$725.4K$0—-$725.4K
Page 1 of 1
Opaleye Management Inc. — 13F Holdings — Q4 2023 | TickerTrail